Literature DB >> 25207086

Onychomycosis Case Developing during Interferon Treatment.

Nazan Tuna1, Mustafa Teoman Erdem2, Oğuz Karabay1.   

Abstract

Entities:  

Year:  2013        PMID: 25207086      PMCID: PMC4116032          DOI: 10.5152/balkanmedj.2012.115

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


× No keyword cloud information.
  11 in total

1.  Interferon-gamma production in peripheral lymphocytes of patients with tinea pedis: comparison of patients with and without tinea unguium.

Authors:  T Koga; A Shimizu; J Nakayama
Journal:  Med Mycol       Date:  2001-02       Impact factor: 4.076

2.  Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment.

Authors:  F Vázquez-López; J A Manjón-Haces; R Pérez-Alvarez; N Pérez-Oliva
Journal:  Br J Dermatol       Date:  2004-05       Impact factor: 9.302

Review 3.  Hepatitis B therapy.

Authors:  Hellan Kwon; Anna S Lok
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-22       Impact factor: 46.802

Review 4.  Onychomycosis: newer insights in pathogenesis and diagnosis.

Authors:  Chander Grover; Ananta Khurana
Journal:  Indian J Dermatol Venereol Leprol       Date:  2012 May-Jun       Impact factor: 2.545

5.  Onychomycosis caused by Aspergillus fumigatus. Report of a case.

Authors:  S A Rosenthal; R Stritzler; J Vilafane
Journal:  Arch Dermatol       Date:  1968-06

Review 6.  Cutaneous side effects associated with interferon-alpha therapy: a review.

Authors:  L W Chang; M Liranzo; W F Bergfeld
Journal:  Cutis       Date:  1995-09

7.  Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis C.

Authors:  Elif Doyuk Kartal; Hasan Colak; Ilhan Ozgunes; Gaye Usluer
Journal:  Chemotherapy       Date:  2005-05-09       Impact factor: 2.544

8.  Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients.

Authors:  O Dereure; N Raison-Peyron; D Larrey; F Blanc; J-J Guilhou
Journal:  Br J Dermatol       Date:  2002-12       Impact factor: 9.302

9.  Cutaneous aspergillosis in a lung transplant recipient.

Authors:  A Ramos; P Ussetti; R Laporta; M T Lázaro; I Sánchez-Romero
Journal:  Transpl Infect Dis       Date:  2009-07-19       Impact factor: 2.228

10.  Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection.

Authors:  Elif Doyuk Kartal; Saygn Nayman Alpat; Ilhan Ozgunes; Gaye Usluer
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-09       Impact factor: 2.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.